Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes
We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes|
- Birthweight centile [ Time Frame: Delivery ] [ Designated as safety issue: No ]
|Study Start Date:||December 2002|
|Study Completion Date:||May 2008|
|Primary Completion Date:||September 2006 (Final data collection date for primary outcome measure)|
Device: Continuous Glucose Monitor
Patients are recruited for 3 day continuous glucose monitoring (CGM) plus self-blood glucose monitoring followed by routine diabetes screening at 26-28 weeks gestation to determine if maternal blood glucose excursions correlate with deviation from optimized birth weight.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00186004
|United States, California|
|Stanford University School of Medicine|
|Stanford, California, United States, 94305|
|Principal Investigator:||Yasser Yehia El-Sayed||Stanford University|